RANDI GAINES: Open Payments
NPI 1306526272 · SALISBURY, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,942 in 89 payments from 16 companies in 2025. Trend: 2023 $0 · 2024 $874 · 2025 $1,942
Food & beverage: $1,915Education: $27
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $293 |
| Otsuka America Pharmaceutical, Inc. | 13 | $281 |
| E.R. Squibb & Sons, L.L.C. | 9 | $199 |
| Neurocrine BioSciences, Inc. | 7 | $187 |
| Teva Pharmaceuticals USA, Inc. | 6 | $164 |
| Vanda Pharmaceuticals Inc. | 8 | $145 |
| Alkermes, Inc. | 5 | $132 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 6 | $126 |
| Janssen Pharmaceuticals, Inc | 4 | $86 |
| Collegium Pharmaceutical, Inc. | 5 | $81 |
Products named: VRAYLAR, REXULTI, COBENFY, INGREZZA, UZEDY, ARISTADA, CAPLYTA, INVEGA SUSTENNA.
Industry payments across NC — which companies pay providers there.
